StockData
OnKure Therapeutics, Inc. logo

OnKure Therapeutics, Inc. (OKUR) operating KPIs

OKURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/30
$2.62+0.00 (0.00%)

Close on Oct 30, 2026Market cap $106.10MP/E –Yield –

KPIs

Operating metrics that drive OnKure Therapeutics's business

Rentable area (sq ft)Q1 26Q3 25Q2 25Q1 25YoY
Rentable area14,79014,79014,79014,7900.0%

Counts and sizes OnKure Therapeutics tags in the notes of its 10-K and 10-Q filings (XBRL), as of the end of each quarter. Breakdowns follow the company's own labels; at most 15 are shown per metric. A fuller KPI sheet built from earnings releases and presentations is on the way. See how companies compare on these metrics.